Corporate Governance

Corporate Governance Overview

The Board of Directors of Kymera Therapeutics (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.

Leadership Team

Please click here.

Committee Composition

	Audit Committee	Compensation Committee	Nominating and Corporate Governance Committee
Jeff Albers		Compensation Committee
Bruce Booth			Nominating and Corporate Governance Committee
Pamela Esposito	Audit Committee		Nominating and Corporate Governance Committee
Joanna Horobin	Audit Committee		Nominating and Corporate Governance Committee
Gorjan Hrustanovic			Nominating and Corporate Governance Committee
John Maraganore		Compensation Committee
Leigh Morgan		Compensation Committee	Nominating and Corporate Governance Committee
Elena Ridloff	Audit Committee

= Chairperson = Member

Investors